Adaptive Biotechnologies plans to sell up to 9.2M shares; revenue grew 52% in 2019 - GeekWire
Adaptive Biotechnologies Corporation (ADPT) Stock Price, News & Info | The Motley Fool
Forget Beyond Meat — Adaptive Biotechnologies just spiked 95% in its public trading debut, marking the year's best post-IPO pop (ADPT) | Markets Insider
Adaptive TCR Corporation Changes Name to Adaptive Biotechnologies | BioSpace
Insiders of Adaptive Biotechnologies Corporation (NASDAQ:ADPT) must have made a tidy sum after selling stock currently worth US$35.34 at US$39.64 | Nasdaq
Adaptive Biotechnologies: A Platform Play For Immune Driven Medicine (NASDAQ:ADPT) | Seeking Alpha